Literature DB >> 29019044

Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review.

Francesca Ambrosi1, Alberto Righi2, Costantino Ricci1, Lori A Erickson3, Ricardo V Lloyd4, Sofia Asioli5.   

Abstract

Papillary thyroid carcinoma is the most common thyroid malignancy and it is usually associated with a good prognosis. However, recurrence, metastases, and cancer death may occur in 10 to 15% of patients with more aggressive types of papillary thyroid carcinoma, such as tall cell, columnar cell, solid variant, or the more recently described hobnail variant of papillary thyroid carcinoma. Papillary thyroid carcinoma with a prominent hobnail pattern is a moderately differentiated papillary thyroid carcinoma variant with aggressive clinical behavior and significant mortality. The hobnail variant of papillary thyroid carcinoma shows prominent hobnail features, which have also been referred to as micropapillary. The typical hobnail/micropapillary morphological features show loss of cellular polarity/cohesiveness and support an epithelial-mesenchymal transition as a possible mechanism of metastasis. BRAF p.V600E is the most common mutation in papillary thyroid carcinoma, including the hobnail variant; recent and continuing studies are focused on defining other molecular anomalies that may be useful for prognostic stratification and may provide therapeutic targets.

Entities:  

Keywords:  Aggressive variant; BRAF mutation; Epithelial-mesenchymal transition; Hobnail; Papillary thyroid carcinoma

Mesh:

Year:  2017        PMID: 29019044     DOI: 10.1007/s12022-017-9502-7

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  34 in total

1.  Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases.

Authors:  Jorge Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  2010-06       Impact factor: 6.394

Review 2.  Alterations of the BRAF gene in thyroid tumors.

Authors:  Raffaele Ciampi; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

3.  Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.

Authors:  Zhiyan Liu; Kennichi Kakudo; Yanhua Bai; Yaqiong Li; Takashi Ozaki; Akira Miyauchi; Emiko Taniguchi; Ichiro Mori
Journal:  J Clin Pathol       Date:  2011-02-04       Impact factor: 3.411

4.  Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.

Authors:  Anne Marie Amacher; Bella Goyal; James S Lewis; Samir K El-Mofty; Rebecca D Chernock
Journal:  Am J Surg Pathol       Date:  2015-02       Impact factor: 6.394

5.  Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior.

Authors:  Sofia Asioli; Lori A Erickson; Alberto Righi; Ricardo V Lloyd
Journal:  Hum Pathol       Date:  2012-10-01       Impact factor: 3.466

6.  Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.

Authors:  Libero Santarpia; Adel K El-Naggar; Gilbert J Cote; Jeffrey N Myers; Steven I Sherman
Journal:  J Clin Endocrinol Metab       Date:  2007-11-07       Impact factor: 5.958

7.  Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population.

Authors:  Jehad Abubaker; Zeenath Jehan; Prashant Bavi; Mehar Sultana; Sayer Al-Harbi; Muna Ibrahim; Abdulrahman Al-Nuaim; Mohammed Ahmed; Tarek Amin; Maha Al-Fehaily; Osama Al-Sanea; Fouad Al-Dayel; Shahab Uddin; Khawla S Al-Kuraya
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

8.  RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.

Authors:  Cristina Romei; Rossella Elisei
Journal:  Front Endocrinol (Lausanne)       Date:  2012-04-11       Impact factor: 5.555

9.  Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.

Authors:  Lianghong Teng; Wanglong Deng; Junliang Lu; Jing Zhang; Xinyu Ren; Huanli Duan; Shannon Chuai; Feidie Duan; Wei Gao; Tao Lu; Huanwen Wu; Zhiyong Liang
Journal:  Oncotarget       Date:  2017-03-28

10.  Evolution of resistance to thyroid cancer therapy.

Authors:  Carmelo Nucera
Journal:  Aging (Albany NY)       Date:  2016-08       Impact factor: 5.682

View more
  12 in total

Review 1.  Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma.

Authors:  Tyler Janovitz; Justine A Barletta
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

Review 2.  Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.

Authors:  Paula Soares; Antónia Afonso Póvoa; Miguel Melo; João Vinagre; Valdemar Máximo; Catarina Eloy; José Manuel Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2021-03-02       Impact factor: 3.943

Review 3.  Aggressive variants of follicular cell-derived thyroid carcinoma: an overview.

Authors:  Cristina Pizzimenti; Vincenzo Fiorentino; Antonio Ieni; Maurizio Martini; Giovanni Tuccari; Maria Lentini; Guido Fadda
Journal:  Endocrine       Date:  2022-07-21       Impact factor: 3.925

4.  Sonographic appearances of hobnail papillary thyroid carcinoma: A case report of a rare tumour.

Authors:  Dilhara Karunaratne; Ting-Ting Zhang; Zainab Al Shiekh Ali; Andrew Moore; Paul Kirkland; David Howlett
Journal:  Ultrasound       Date:  2021-08-23

Review 5.  Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine.

Authors:  Antonio Ieni; Roberto Vita; Cristina Pizzimenti; Salvatore Benvenga; Giovanni Tuccari
Journal:  J Pers Med       Date:  2021-04-23

Review 6.  Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers.

Authors:  José Manuel Cameselle-Teijeiro; Catarina Eloy; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2020-07-06       Impact factor: 3.943

7.  First ever case report of co-occurrence of hobnail variant of papillary thyroid carcinoma and intrathyroid parathyroid adenoma in the same thyroid lobe.

Authors:  Omer Al-Yahri; Abdelrahman Abdelaal; Walid El Ansari; Hanan Farghaly; Khaled Murshed; Mahmoud A Zirie; Mohamed S Al Hassan
Journal:  Int J Surg Case Rep       Date:  2020-05-05

8.  Expression of Class III Beta-Tubulin Is Associated with Invasive Potential and Poor Prognosis in Thyroid Carcinoma.

Authors:  Hee Young Na; Mira Park; Young A Kim; Jae Kyung Won; Young Joo Park; Sun Ah Shin; Sejoon Lee; Sohee Oh; Ji Eun Kim
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

9.  Oral Contraceptive Steroids Promote Papillary Thyroid Cancer Metastasis by Targeting Angiogenesis and Epithelial-Mesenchymal Transition.

Authors:  Mohammad Hossein Dehghan; Mohammad Reza Ashrafi; Mehdi Hedayati; Setareh Shivaee; Sadegh Rajabi
Journal:  Int J Mol Cell Med       Date:  2022-01-10

Review 10.  Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.

Authors:  Andrés Coca-Pelaz; Jatin P Shah; Juan C Hernandez-Prera; Ronald A Ghossein; Juan P Rodrigo; Dana M Hartl; Kerry D Olsen; Ashok R Shaha; Mark Zafereo; Carlos Suarez; Iain J Nixon; Gregory W Randolph; Antti A Mäkitie; Luiz P Kowalski; Vincent Vander Poorten; Alvaro Sanabria; Orlando Guntinas-Lichius; Ricard Simo; Peter Zbären; Peter Angelos; Avi Khafif; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2020-06-01       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.